VTAK
Catheter Precision Inc.
NYSE MKT: VTAK · HEALTHCARE · MEDICAL DEVICES
$0.94
+0.77% today
Updated 2026-04-29
Market cap
$2.51M
P/E ratio
—
P/S ratio
3.07x
EPS (TTM)
$-15.90
Dividend yield
—
52W range
$1 – $16
Volume
1.4M
Catheter Precision Inc. (VTAK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,204.00%
ROE
-192.30%
ROA
-34.90%
Debt/equity
0.51x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $5.98M | $-4.20M | 47.49% | -70.25% | -70.31% |
| 2017 | $5.87M | $-17.77M | 29.05% | -302.56% | -302.64% |
| 2018 | $6.26M | $-30.83M | 32.78% | -498.00% | -492.76% |
| 2019 | $7.20M | $-56.96M | -22.93% | -801.92% | -791.18% |
| 2020 | $4.41M | $-36.05M | -24.45% | -818.59% | -818.27% |
| 2021 | $22000.00 | $-25.07M | -6,990.91% | -133,027.27% | -113,954.55% |
| 2022 | $14000.00 | $-26.86M | -1,050.00% | -192,578.57% | -191,892.86% |
| 2023 | $442000.00 | $-70.57M | 93.21% | -17,673.98% | -15,966.52% |
| 2024 | $420000.00 | $-16.64M | 90.00% | -2,676.90% | -3,962.62% |
| 2025 | $819000.00 | $-17.18M | 92.31% | -1,487.30% | -2,098.05% |